In our September 2023 issue of Medical Liability Monitor, we summarize results from the second quarter for medical professional liability (MPL) specialty writers. The data used in our analysis covers 20 years and consists of aggregate statutory financial information compiled from S&P Global Market Intelligence. The current composite includes 166 MPL specialty companies with total direct written premium of more than $6.5 billion in 2022.
In this issue, we discuss the following observations:
- 2023 premium growth
- Unfavorable reserve development persists
- Combined ratios back on the rise
- Indemnity payments continue to surge after COVID-19 slowdown
- Policyholders’ surplus holds steady